GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GC Cell Corp (XKRX:144510) » Definitions » Loans Receivable

GC Cell (XKRX:144510) Loans Receivable : ₩0 Mil (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is GC Cell Loans Receivable?

GC Cell's Loans Receivable for the quarter that ended in Jun. 2024 was ₩0 Mil.


GC Cell Loans Receivable Historical Data

The historical data trend for GC Cell's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GC Cell Loans Receivable Chart

GC Cell Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

GC Cell Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

GC Cell Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


GC Cell Loans Receivable Related Terms

Thank you for viewing the detailed overview of GC Cell's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


GC Cell Business Description

Traded in Other Exchanges
N/A
Address
30 beongil to giheung-gu, Gyeonggi, 107 Lee Hyun, Yongin, KOR, 16 924
GC Cell Corp engages in the provision of anti-cancer immunotherapy. The company is developing an anticancer drug, which is in Phase II clinical trials; and stem cell treatment drugs. It also provides cell banking, sample inspection, clinical trial, and bio logistics services.

GC Cell Headlines

No Headlines